Table 1: Echocardiographic measurements in control and patient groups.
|
Parameters |
Control group |
Patient group |
||
|
|
|
baseline |
12 weeks |
24 weeks |
|
Interventricular Septum (mm) |
8.3 ± 0.2 |
13 ± 0.6++ |
11 ± 0.6+** |
10 ± 0.4** |
|
Posterior Wall (mm) |
8.4 ± 0.2 |
11 ± 0.5+ |
10 ± 0.5 |
10 ± 0.4 |
|
Left Ventricular End-Diastolic Diameter (mm) |
52 ± 1.3 |
47 ± 2.0 |
48 ± 2.0 |
48 ± 1.1 |
|
Left Ventricular End-Systolic Diameter (mm) |
25 ± 2.1 |
26 ± 1.2 |
26 ± 1.4 |
26 ± 1.0 |
|
Ejection Fraction (%) |
73 ± 2.2 |
77 ± 2.1 |
76 ± 2.1 |
76 ± 1.1 |
|
Relative wall thickness ratio |
0.32 ± 0.2 |
0.51 ± 0.4++ |
0.45 ± 0.3+** |
0.42 ± 0.1+** |
|
Wall Stress (x103dynes/cm2) |
40 ± 4.4 |
45 ± 0.0 |
40 ± 4.0 |
41 ± 3.0 |
|
Let Ventricular Mass Index (g/m2) |
106 ± 7.4 |
153 ± 7.1 |
138 ± 7.5+** |
129 ± 8+** |
Table 1: Echocardiographic measurements in control and patient groups.
Control-patients +p < 0.05 ++p < 0.01
Follow-up period **p < 0.01